BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9242530)

  • 1. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
    Ohara A; Kojima S; Hamajima N; Tsuchida M; Imashuku S; Ohta S; Sasaki H; Okamura J; Sugita K; Kigasawa H; Kiriyama Y; Akatsuka J; Tsukimoto I
    Blood; 1997 Aug; 90(3):1009-13. PubMed ID: 9242530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
    Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
    Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.
    Kojima S; Ohara A; Tsuchida M; Kudoh T; Hanada R; Okimoto Y; Kaneko T; Takano T; Ikuta K; Tsukimoto I;
    Blood; 2002 Aug; 100(3):786-90. PubMed ID: 12130487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
    Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
    Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
    Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
    Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults.
    Kaito K; Kobayashi M; Katayama T; Masuoka H; Shimada T; Nishiwaki K; Sekita T; Otsubo H; Ogasawara Y; Hosoya T
    Br J Haematol; 1998 Nov; 103(2):297-303. PubMed ID: 9827895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
    Kalra R; Dale D; Freedman M; Bonilla MA; Weinblatt M; Ganser A; Bowman P; Abish S; Priest J; Oseas RS; Olson K; Paderanga D; Shannon K
    Blood; 1995 Dec; 86(12):4579-86. PubMed ID: 8541548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors.
    Shibuya A; Ishii S; Obinata K
    Hematology; 2002 Oct; 7(5):301-4. PubMed ID: 12850817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Sun L; Babushok DV
    Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor (G-CSF) dependent hematopoiesis with monosomy 7 in a patient with severe aplastic anemia after ATG/CsA/G-CSF combined therapy.
    Nishimura M; Yamada T; Andoh T; Tao T; Emoto M; Ohji T; Matsuda K; Kameda N; Satoh Y; Matsutani A; Azuno Y; Oka Y
    Int J Hematol; 1998 Aug; 68(2):203-11. PubMed ID: 9803678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).
    Socie G; Mary JY; Schrezenmeier H; Marsh J; Bacigalupo A; Locasciulli A; Fuehrer M; Bekassy A; Tichelli A; Passweg J
    Blood; 2007 Apr; 109(7):2794-6. PubMed ID: 17110459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of mutations in the granulocyte colony-stimulating factor (G-CSF) receptor gene in patients with myelodysplastic syndrome/acute myeloblastic leukaemia occurring after treatment of aplastic anaemia with G-CSF.
    Kudo K; Nagai H; Numata S; Ichihara M; Kinoshita T; Horibe K; Kato K; Matsuyama T; Kodera Y; Kojima S
    Br J Haematol; 2000 Nov; 111(2):656-8. PubMed ID: 11122117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
    Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
    Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of severe aplastic anemia into myelodysplastic syndrome with monosomy 7: monoclonal origin detected by HUMARA gene analysis during the aplastic anemia phase.
    Sashida G; Tauchi T; Katagiri T; Kuriya S; Ohyashiki K
    Haematologica; 2000 Jun; 85(6):665-6. PubMed ID: 10870128
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
    Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
    Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction.
    Yamazaki E; Kanamori H; Taguchi J; Harano H; Mohri H; Okubo T
    Blood Cells Mol Dis; 1997 Aug; 23(2):213-8. PubMed ID: 9236159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
    Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
    Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
    Freedman MH; Alter BP
    Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.